Glanzmann's thrombasthenia: meeting the anticoagulation challenge.
Hematology/Oncology, Mount Sinai Hospital, New York City, NY, USA.
A
A
Binder
Medicine - Hematology/Oncology, Mount Sinai Hospital, New York City, NY, USA.
L
L
Aledort
D015119:Aminocaproic Acid / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D015942:Factor VIIa / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D011994:Recombinant Proteins / Q000627:therapeutic use; D013915:Thrombasthenia / Q000175:diagnosis* / Q000628:therapy; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D007518:Isoantibodies; D011994:Recombinant Proteins; D000077144:Clopidogrel; C103587:recombinant FVIIa; D015942:Factor VIIa; D013988:Ticlopidine; D001241:Aspirin; D015119:Aminocaproic Acid